News

Eli Lilly has gone on to announce its plans to build a $5bn drug manufacturing plant in Virginia on September 16. This announcement comes amidst the pressure from President Donald Trump to get more drug manufacturing to the U.S....

The South Korean government has gone on to hold the Bio Innovation Roundtable at Songdo Convensia in Incheon as per the theme K-Bio: Accelerating Innovation. The Ministry of Food and Drug Safety, the Ministry of Economy and Finance, the...

Matica Biotechnology, Inc., which happens to be a leading contract development and manufacturing organization (CDMO) that specializes in viral vector manufacturing in terms of cell and gene therapies, announced on September 15, a strategic commercial manufacturing deal along with...

Dental care has moved well beyond fillings and routine cleanings. In the past few years, the field has seen fast-moving advances across regenerative medicine, digital manufacturing, artificial intelligence (AI) and minimally invasive therapies. These breakthroughs promise better diagnostics, faster...

Medication adherence has long been one of healthcare’s toughest challenges. Even the most effective treatment plan fails if patients don’t take their medications consistently. This isn’t just a patient-level problem, though; it has massive implications for healthcare systems, pharmaceutical...

Russia and Vietnam have gone on to officially formalize a major collaboration in healthcare, with Russia going ahead with the biopharma technology transfer to Vietnam. It is well to be noted that this agreement was officially concluded at a signing...

US President Donald Trump is all set to order his health department to go ahead and crack down on direct-to-consumer (D2C) pharmaceutical advertising as per a new memorandum that was inked on September 9, 2025. This push, which happens to...